tirzepatide fda weight loss Wins Approval for FDA says shortage of GLP-1

For patients seeking tirzepatide for weight loss not Mounjaro

21st century is the time when weight loss is the expressed aim set by billions of people

Additionally, in patients with metastatic castrate-resistant prostate cancer and progression following docetaxel chemotherapy, further life-prolonging treatment options should be taken into account in selected cases (e.g., novel anti-androgens, radium-223, and olaparib, etc.)

Forty-four healthy PMW were randomized to CIT (6 g), CIT+GSH (2 g + 200 mg: Setria ) or placebo (PL) for 4 weeks

The AE frequency increased in a dose-dependent fashion except for rates of treatment discontinuation and constipation

A blessing to the community